P3‐233: PLASMA PRIMARY FATTY AMIDES ASSOCIATE TO CSF AMYLOID LEVELS AND ALZHEIMER'S DISEASE PROGRESSION IN THE EMIF‐AD BIOMARKER DISCOVERY COHORT

Alzheimer's disease (AD) is a progressive neurological disease that is irreversible. A critical and as-yet unmet need in AD is the discovery of peripheral molecules that can act as biomarkers in the early stages of AD. Given that brain pathology precedes clinical symptom onset, small molecule markers associated to pathology could provide new potential drug targets and molecules that are relatively easy to measure. Here in this study, we employed...